CRS

Carpenter Technology Corporation

73
Fundamentals77/ 100
Valuation76/ 100
Upside potential80/ 100
Risk potential16/ 100

CRS's fundamentals are strong and it looks cheap: trading at 26x earnings, below its usual 38x. Analysts expect strong earnings growth.

EOSE

Eos Energy Enterprises, Inc.

There isn't enough reported data to score EOSE yet.

CRS Fundamentals

MetricStatus
Healthy
Strong
Healthy
Healthy

CRS's revenue, profitability, cash flow and balance sheet are all currently healthy.

EOSE Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

CRS PE Valuation

CHEAPFAIREXPENSIVE35x69x104x139x
CHEAPFAIREXPENSIVE35x69x104x139x
LevelPEPriceVs current
Cheap20x$222-26%
Forward22x$300โ€”
Current26x$300โ€”
Fair38x$427+43%
Expensive50x$572+91%

Historical ranges are pointers, not guarantees.

CRS's PE is in its cheap range at 26x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.

EOSE PE Valuation

EOSE has no meaningful PE right now: it lost money over the past year.

CRS Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Strongly improving
Limited
High

Analysts expect earnings and revenue growth for CRS, with profitability improving.

EOSE Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
Low

Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

CRS Risk to reward

ScenarioChangePrice
Upside+61%$482.18
Downside-16%$252.56

Calculated from the latest close: $299.55 on Nov 12.

There is not enough scenario data to compare CRS and EOSE's risk to reward.

EOSE Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.81 on Nov 12.

There is not enough scenario data to compare CRS and EOSE's risk to reward.

CRS Earnings Per Share

Q4 2023: $2.88Q1 2024: $2.62Q2 2024: $3.70Q3 2024: $4.49Q4 2024: $5.30Q1 2025: $7.06Q2 2025: $7.42Q3 2025: $8.18Q4 2025: $8.61Q1 2026: $9.50Q2 2026: $10.52Q3 2026: $11.34Forward: $13.93
Q4 2023: $2.88Q1 2024: $2.62Q2 2024: $3.70Q3 2024: $4.49Q4 2024: $5.30Q1 2025: $7.06Q2 2025: $7.42Q3 2025: $8.18Q4 2025: $8.61Q1 2026: $9.50Q2 2026: $10.52Q3 2026: $11.34Forward: $13.93
QuarterTTM EPSYoY
Forward$13.93+23%
Q3 2026$11.34+39%
Q2 2026$10.52+42%
Q1 2026$9.50+35%
Q4 2025$8.61+62%
Q3 2025$8.18+82%
Q2 2025$7.42+101%
Q1 2025$7.06+169%
Q4 2024$5.30+84%

CRS has the stronger earnings trend. Trailing diluted EPS is up 39% for CRS versus EOSE down 224%.

EOSE Earnings Per Share

Q4 2024: $-4.55
Q4 2024: $-4.55
QuarterTTM EPSYoY
Q3 2023-$2.69+$0.85
Q2 2023-$3.76-$1.00
Q1 2023-$3.65-$0.86
Q4 2022-$3.68-$1.32
Q3 2022-$3.54+$5.19

EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.

CRS Quarterly Revenue

Q4 2023: $624MQ1 2024: $685MQ2 2024: $799MQ3 2024: $718MQ4 2024: $677MQ1 2025: $727MQ2 2025: $756MQ3 2025: $734MQ4 2025: $728MQ1 2026: $812MQ2 2026: $851MQ3 2026: $798M
Q4 2023: $624MQ1 2024: $685MQ2 2024: $799MQ3 2024: $718MQ4 2024: $677MQ1 2025: $727MQ2 2025: $756MQ3 2025: $734MQ4 2025: $728MQ1 2026: $812MQ2 2026: $851MQ3 2026: $798M
QuarterRevenueYoY
Q3 2026$798.2M+8.8%
Q2 2026$851M+13%
Q1 2026$811.5M+12%
Q4 2025$728M+7.5%
Q3 2025$733.7M+2.2%
Q2 2025$755.6M-5.4%
Q1 2025$727M+6.1%
Q4 2024$676.9M+8.4%

CRS's revenue is recovering but still below its 2023 peak: $798M last quarter, up 8.8% from the same quarter a year ago.

EOSE Quarterly Revenue

Q4 2023: $7MQ1 2024: $7MQ2 2024: $898,000Q3 2024: $854,000Q4 2024: $7MQ1 2025: $10MQ2 2025: $15MQ3 2025: $31MQ4 2025: $58MQ1 2026: $57MQ2 2026: $69MQ3 2026: $83M
Q4 2023: $7MQ1 2024: $7MQ2 2024: $898,000Q3 2024: $854,000Q4 2024: $7MQ1 2025: $10MQ2 2025: $15MQ3 2025: $31MQ4 2025: $58MQ1 2026: $57MQ2 2026: $69MQ3 2026: $83M
QuarterRevenueYoY
Q3 2026$82.7M+171%
Q2 2026$68.8M+351%
Q1 2026$57M+445%
Q4 2025$58M+700%
Q3 2025$30.5M+3473%
Q2 2025$15.2M+1597%
Q1 2025$10.5M+58%
Q4 2024$7.3M+9.7%

EOSE has the edge over CRS on sales, with more consistent year-over-year improvement.

CRS Free Cash Flow

Q4 2023: โˆ’$11MQ1 2024: $62MQ2 2024: $142MQ3 2024: $13MQ4 2024: $39MQ1 2025: $34MQ2 2025: $200MQ3 2025: โˆ’$3MQ4 2025: $86MQ1 2026: $125MQ2 2026: $155MQ3 2026: โˆ’$25M
Q4 2023: โˆ’$11MQ1 2024: $62MQ2 2024: $142MQ3 2024: $13MQ4 2024: $39MQ1 2025: $34MQ2 2025: $200MQ3 2025: โˆ’$3MQ4 2025: $86MQ1 2026: $125MQ2 2026: $155MQ3 2026: โˆ’$25M
QuarterFree cash flowYoY
Q3 2026-$24.9M-$21.5M
Q2 2026$155M-23%
Q1 2026$124.8M+267%
Q4 2025$85.9M+123%
Q3 2025-$3.4M-126%
Q2 2025$200.1M+41%
Q1 2025$34M-45%
Q4 2024$38.6M+$49.4M

CRS has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.

EOSE Free Cash Flow

Q4 2023: โˆ’$46MQ1 2024: โˆ’$45MQ2 2024: โˆ’$33MQ3 2024: โˆ’$54MQ4 2024: โˆ’$56MQ1 2025: โˆ’$34MQ2 2025: โˆ’$73MQ3 2025: โˆ’$83MQ4 2025: โˆ’$75MQ1 2026: โˆ’$155MQ2 2026: โˆ’$107MQ3 2026: โˆ’$105M
Q4 2023: โˆ’$46MQ1 2024: โˆ’$45MQ2 2024: โˆ’$33MQ3 2024: โˆ’$54MQ4 2024: โˆ’$56MQ1 2025: โˆ’$34MQ2 2025: โˆ’$73MQ3 2025: โˆ’$83MQ4 2025: โˆ’$75MQ1 2026: โˆ’$155MQ2 2026: โˆ’$107MQ3 2026: โˆ’$105M
QuarterFree cash flowYoY
Q3 2026-$105.1M-$22.4M
Q2 2026-$107.4M-$34.3M
Q1 2026-$154.8M-$121M
Q4 2025-$75.2M-$19.5M
Q3 2025-$82.7M-$28.5M
Q2 2025-$73.2M-$40.6M
Q1 2025-$33.8M+$10.7M
Q4 2024-$55.8M-$10.2M

EOSE has burned cash in almost every quarter: โˆ’$443M over the past year, against โˆ’$246M the year before.

CRS Total Shares

Q4 2023: 50MQ1 2024: 50MQ2 2024: 50MQ3 2024: 51MQ4 2024: 51MQ1 2025: 51MQ2 2025: 51MQ3 2025: 50MQ4 2025: 50MQ1 2026: 50MQ2 2026: 50MQ3 2026: 50M
Q4 2023: 50MQ1 2024: 50MQ2 2024: 50MQ3 2024: 51MQ4 2024: 51MQ1 2025: 51MQ2 2025: 51MQ3 2025: 50MQ4 2025: 50MQ1 2026: 50MQ2 2026: 50MQ3 2026: 50M
PeriodChange %Net change
Quarterly-0.4%-200K shares
1 year-0.8%-400K shares
3 years+0.2%+100K shares
5 years+3.1%+1.5M shares
Available history+3.1%+1.5M shares

CRS has the edge over EOSE on shareholder dilution, with a more favorable share count trend.

EOSE Total Shares

Q1 2024: 201MQ2 2024: 211MQ3 2024: 217MQ4 2024: 212MQ2 2025: 238MQ3 2025: 272MQ2 2026: 340MQ3 2026: 553M
Q1 2024: 201MQ2 2024: 211MQ3 2024: 217MQ4 2024: 212MQ2 2025: 238MQ3 2025: 272MQ2 2026: 340MQ3 2026: 553M
PeriodChange %Net change
Quarterly+63%+213M shares
1 year+161%+341M shares
3 years+888%+497M shares

EOSE has 553M diluted shares, up 161% from a year ago.

CRS Net Leverage

Q4 2023: 1.9xQ1 2024: 1.6xQ2 2024: 1.1xQ3 2024: 1.1xQ4 2024: 1.0xQ1 2025: 0.9xQ2 2025: 0.6xQ3 2025: 0.7xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.4xQ3 2026: 0.6x
Q4 2023: 1.9xQ1 2024: 1.6xQ2 2024: 1.1xQ3 2024: 1.1xQ4 2024: 1.0xQ1 2025: 0.9xQ2 2025: 0.6xQ3 2025: 0.7xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.4xQ3 2026: 0.6x
QuarterNet LeverageStatus
Q3 20260.6xVery low
Q2 20260.4xVery low
Q1 20260.5xVery low
Q4 20250.6xVery low
Q3 20250.7xVery low
Q2 20250.6xVery low
Q1 20250.9xVery low
Q4 20241.0xVery low

CRS's net debt is less than a year of its operating earnings (EBITDA).

EOSE Net Leverage

EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CRS Weekly Momentum

MetricValueStatus
RSI32.0Neutral
Stochastic4.9Oversold

CRS's weekly RSI is 32 (neutral) and its Stochastic is 5 (oversold).

EOSE Weekly Momentum

MetricValueStatus
RSI32.5Neutral
Stochastic7.4Oversold

EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

CRS PE vs Industrials Sector

MetricCRSSector medianRelative
PE26x24x9.9% above
PE %225836 pts below

CRS is trading at 26x earnings, in line with the Industrials sector's median of 24x.

EOSE PE vs Industrials Sector

EOSE has no meaningful PE right now: it lost money over the past year.

CRS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$336.711% below
20 week MA$448.133% below
50 week MA$420.429% below
100 week MA$326.68.3% below
200 week MA$206.445% above

CRS has the edge over EOSE on trend strength, trading above more of its moving averages.

EOSE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.2419% below
20 week MA$3.2845% below
50 week MA$7.0174% below
100 week MA$7.1075% below
200 week MA$4.5360% below

EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.

CRS Yearly ROI

YearStart priceEnd priceROI
2020$50.3$28.6-43%
2021$28.6$29.0+1.2%
2022$29.0$37.8+30%
2023$37.8$70.8+87%
2024$70.8$170.7+141%
2025$170.7$334.4+96%
2026 YTD$334.4$299.6-10%

CRS has the edge over EOSE on returns for 2026, with the stronger performance.

EOSE Yearly ROI

YearStart priceEnd priceROI
2020$9.72$19.2+98%
2021$19.2$8.57-55%
2022$8.57$1.08-87%
2023$1.08$1.09+0.9%
2024$1.09$5.17+374%
2025$5.17$11.9+129%
2026 YTD$11.9$1.81-85%

EOSE's yearly returns have swung widely, from +374% in 2024 to โˆ’87% in 2022. It's down 85% so far in 2026.

Give your agent the market.

Get API key